Prothena Corp Public (PRTA) Total Liabilities (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Total Liabilities came in at $37.3 million in Q1 2026, down 35.34% year-on-year from $57.7 million in Q1 2025, and down 19.54% quarter-over-quarter from $46.3 million in Q4 2025.
Prothena Corp Public (PRTA) Total Liabilities (2012 - 2026) Analysis & Trends
Prothena Corp Public's Total Liabilities history runs 15 years deep, the most recent figure standing at $37.3 million for Q1 2026.
- On a quarterly basis, Total Liabilities fell 35.34% year-over-year to $37.3 million in Q1 2026; TTM through Mar 2026 was $37.3 million, a 35.34% decrease from a year earlier, with the FY2025 full-year figure at $46.3 million, down 23.02% from the prior year.
- Total Liabilities retreated to $37.3 million in Q1 2026 per PRTA's latest filing, from $46.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $149.8 million in Q3 2022 and bottomed at $37.3 million in Q1 2026.
- The 5-year median for Total Liabilities is $120.8 million (2024), against an average of $99.3 million.
- Across the five-year window, Total Liabilities slumped 55.43% in 2024 and increased 17.42% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $136.0 million in 2022, then dropped by 0.72% to $135.0 million in 2023, then slumped by 55.43% to $60.2 million in 2024, then decreased by 23.02% to $46.3 million in 2025, then declined by 19.54% to $37.3 million in 2026.
- Per Business Quant, the three latest PRTA Total Liabilities figures stand at $37.3 million (Q1 2026), $46.3 million (Q4 2025), and $57.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 753.82 Mn |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - | 37.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.28 Mn |
| Dec 31, 2025 | 46.33 Mn |
| Sep 30, 2025 | 57.64 Mn |
| Jun 30, 2025 | 74.74 Mn |
| Mar 31, 2025 | 57.66 Mn |
| Dec 31, 2024 | 60.18 Mn |
| Sep 30, 2024 | 60.89 Mn |
| Jun 30, 2024 | 63.65 Mn |
| Mar 31, 2024 | 120.80 Mn |
| Dec 31, 2023 | 135.02 Mn |
| Sep 30, 2023 | 129.69 Mn |
| Jun 30, 2023 | 138.97 Mn |
| Mar 31, 2023 | 134.18 Mn |
| Dec 31, 2022 | 135.99 Mn |
| Sep 30, 2022 | 149.79 Mn |
| Jun 30, 2022 | 142.29 Mn |
| Mar 31, 2022 | 142.53 Mn |
| Dec 31, 2021 | 143.32 Mn |
| Sep 30, 2021 | 142.23 Mn |
| Jun 30, 2021 | 148.17 Mn |